|
14 May 2020 |
Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age
|
|
14 May 2020 |
CureVac´s Optimized mRNA Platform Provides Positive Pre-Clinical Results at Low Dose for Coronavirus Vaccine Candidate
|
|
14 May 2020 |
VAXIMM Announces First Results from Phase I/II Trial in Progressive Glioblastoma with Oral T-cell Immunotherapy VXM01 in Combination with PD-L1 Inhibitor Avelumab to be Presented at ASCO20 Virtual
|
|
12 May 2020 |
Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
|
|
11 May 2020 |
TolerogenixX Reports Positive Phase Ib Data of its Lead Product to Combat Transplant Rejection
|
|
08 May 2020 |
ZYUS Collaborates with USask’s VIDO-InterVac to Develop a Plant-Based Vaccine for COVID-19
|
|
06 May 2020 |
Predictive Oncology and Dr. Daniel Carter Collaborating to Develop a Potential COVID-19 Vaccine Utilizing Novel Nanoparticle Vaccine Platform, Based on NSP-10
|
|
06 May 2020 |
OSE Immunotherapeutics Announces COVID-19 Prophylactic Vaccine Program
|
|
06 May 2020 |
CEPI seeks to expand COVID-19 vaccine portfolio, focusing on speed and global manufacturing
|
|
05 May 2020 |
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
|
|
04 May 2020 |
Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
|
|
04 May 2020 |
Stallergenes Greer Submits a Marketing Authorisation Application in Europe for Its Sublingual House Dust Mite Allergen Immunotherapy Tablet
|
|
01 May 2020 |
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus
|
|
30 Apr 2020 |
INOVIO expands manufacturing of COVID-19 DNA vaccine INO-4800 with new funding from CEPI
|
|
30 Apr 2020 |
UQ COVID-19 vaccine shown to induce potent protective response in pre-clinical trials
|
|
30 Apr 2020 |
Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15
|
|
30 Apr 2020 |
AstraZeneca and Oxford University announce landmark agreement for COVID-19 vaccine
|
|
29 Apr 2020 |
Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate
|
|
29 Apr 2020 |
Verndari, Inc. Begins Preclinical Testing of COVID-19 Vaccine at University of California, Davis
|
|
29 Apr 2020 |
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference
|
|
29 Apr 2020 |
BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
|
|
28 Apr 2020 |
Shionogi Accelerates Development of Potential COVID-19 Treatments and Vaccine
|
|
28 Apr 2020 |
INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June
|
|
28 Apr 2020 |
Moderna Announces IND Submitted to U.S. FDA for Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
|
|
27 Apr 2020 |
TriLink BioTechnologies and Imperial College London Announce Collaboration to Produce saRNA for Covid-19 Vaccine Development
|
